Cogent Biosciences, Inc. (COGT) earnings
COGT earnings moved a median of -0.19% by the close. Quarterly and annual COGT reports and results, each read against the price at its own news timestamp. Back to the COGT overview →
20 measured COGT earnings events.
Where these COGT earnings landedvs 19 measured COGT earnings reactions
| Middle 50% of COGT earnings reactions | -5.05% to +2.56% |
|---|---|
| Median reaction (to close) | -0.19% |
| Measured reactions | 19 |
Point-in-time · zero look-ahead
Half of the 19 COGT earnings events with a measured close landed between -5.05% and +2.56%; 47% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2026 Financial Results | Press release | +0.67% | — | |
| Cogent Biosciences Reports Recent Business Highlights and First Quarter 2026 Financial Results | Press release | -0.05% | +0.16% | |
| Form 10-Q Cogent Biosciences, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.05% | +0.16% | |
| Form 10-K Cogent Biosciences, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.61% | +4.38% | |
| Form 10-Q Cogent Biosciences, Inc. For: Sep 30 | SEC filing · Form 10-Q | -2.48% | -0.82% | |
| Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2025 Financial Results | Press release | +1.42% | -4.62% | |
| Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2025 Financial Results | Press release | -3.33% | -5.49% | |
| Form 10-Q Cogent Biosciences, Inc. For: Jun 30 | SEC filing · Form 10-Q | -3.33% | -5.49% | |
| Cogent Biosciences Reports First Quarter 2025 Financial Results | Press release | -0.55% | -14.08% | |
| Form 10-Q Cogent Biosciences, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.55% | -14.08% | |
| Form 10-K Cogent Biosciences, Inc. For: Dec 31 | SEC filing · Form 10-K | -1.48% | -6.05% | |
| Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2024 Financial Results | Press release | +2.84% | +1.57% | |
| Form 10-Q Cogent Biosciences, Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.06% | -0.19% | |
| Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2024 Financial Results | Press release | -4.74% | -0.32% | |
| Form 10-Q Cogent Biosciences, Inc. For: Jun 30 | SEC filing · Form 10-Q | -4.74% | -0.32% | |
| Cogent Biosciences Reports First Quarter 2024 Financial Results | Press release | +1.42% | +5.01% | |
| Form 10-Q Cogent Biosciences, Inc. For: Mar 31 | SEC filing · Form 10-Q | +1.42% | +5.01% | |
| Form 10-K Cogent Biosciences, Inc. For: Dec 31 | SEC filing · Form 10-K | +3.31% | +3.45% | |
| Form 10-Q Cogent Biosciences, Inc. For: Sep 30 | SEC filing · Form 10-Q | +2.15% | +1.68% | |
| Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2023 Financial Results | Press release | +2.55% | +4.01% |
Keep exploring
More COGT: analyst actions → · SEC filings → · COGT overview →